NCT01690195 Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01689246 Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01689233 Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT01677754 A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy Status COMPLETED Phase PHASE2
NCT01677572 Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease Status TERMINATED Phase PHASE1
NCT01676935 This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT01672827 Effectiveness of an Electronic Training Program for Orienting and Interpreting [18F]Flutemetamol Positron Emission Tomography (PET) Images Status COMPLETED Phase PHASE3
NCT01662882 A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) Status COMPLETED Phase PHASE2/PHASE3
NCT01661894 Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly Status COMPLETED Phase PHASE1
NCT01661673 Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01660815 A Study of Florbetapir (18F) in Japanese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01656525 A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients Status COMPLETED Phase PHASE1
NCT01652222 Experimental Study to Validate the "Therapeutic Game" CONEM-BETA Status COMPLETED Phase NA
NCT01636596 Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease Status WITHDRAWN Phase NA
NCT01630525 " The Eyes Have it " : Ocular Saccade Abnormalities in Prodromal Alzheimer's Disease Status COMPLETED Phase N/A
NCT01626391 Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease Status TERMINATED Phase PHASE2